CRDL
CRDL
NASDAQ · Pharmaceuticals

Cardiol Therapeutics Inc-A

$1.88
+0.02 (+0.81%)
As of Sep 20, 10:42 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,194.9% upside
Low Target $16.80
Average Target $24.28
High Target $33.59
Current Price $1.88
Current
$1.88
Target
$24.28
$16.80 $24.28 avg $33.59
Scenario Analysis
Bear Case
$16.80
796.0%
Low target
Base Case
$24.28
+1,194.9%
Avg target
Bull Case
$33.59
+1,691.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.23
-42.0% from high
52-Week Low
$1.23
+53.1% from low
Target vs 52W High
$24.28
+651.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +15.8%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.9%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +7.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +20.9%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +192.4%